186 results
Page 6 of 10
6-K
EX-99.5
4djc2dpv3j1cqykv
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
48l9pjry60k2 ffi
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
nkw p2sgbfqjhqqfjn
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
vkek0wl
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
cg06qp9a2z1uq
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
zx8rbwcw e18yqvzuqiw
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
p1fiju1hua ihq
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
66x8xnyz18y zrx9yn
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.1
oe9g75sgostwz
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.1
v4ap7iklw4gvi
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
9u8e qyd51my236
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
wal8ggs ikgdvz
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
qu0fve0jtzaq
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
j69kfs
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
ylgy3
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
y3xlnp7y3p4i0z20k
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
oyqhf54a
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.2
d1mu45qf
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
xo6otoqq9k18hk
26 Nov 18
Current report (foreign)
4:20pm